Skip to main content
OpenTrials
Completed

NCT Number: NCT00733473

Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing

The purpose of this study is to determine if adding nebulized budesonide to the systemic steroid for treatment of acute wheezing has any additive benefit in children who have hospitalized for acute wheezing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Kecioren Education and Training Hospital

Ankara, Kecioren, 06380, Turkey (Türkiye)

About this study

Context: Inhaled steroids reduced admission rates in patients with acute asthma, but it is unclear if there is a benefit of inhaled corticosteroids when used in addition to systemic corticosteroids. There is insufficient evidence that inhaled corticosteroids result in clinically important changes in pulmonary function or clinical scores when used in acute asthma. Similarly, it was mentioned in the Cochrane Database of Systematic Reviews that further research is needed to clarify if there is a benefit of inhaled corticosteroids when used in addition to systemic steroids.

Objective: To determine if adding nebulized budesonide to the systemic steroid for treatment of acute wheezing in hospitalized children has any benefit on, symptom score, duration of hospitalization and time to discharge from hospital.

Study Design/Setting/Participants: A double-blind, randomized, controlled trial of nebulized budesonide versus placebo for children 6 months to 6 years of age who have admitted to the hospital for acute wheezing.

Intervention: Participants will receive standard therapy including SCS, albuterol, and ipratropium bromide and will be randomly assigned to also receive either nebulized BIS or saline.

Study Measures: Differences in asthma scores, vital signs, duration of hospitalization and time to discharge from hospital will be compared between treatment groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children who have recurrent wheezing attacks
  • Children who admitted to the hospital for acute wheezing
  • Clinical asthma score of 3-9
  • Parental/guardian permission (informed consent) and if appropriate, child assent

Exclusion criteria

  • Systemic corticosteroid use in the last 30 days
  • Chronic lung diseases including cystic fibrosis
  • Immunodeficiency
  • Cardiac disease requiring surgery or medications
  • Adverse drug reaction or allergy to budesonide, albuterol, ipratropium bromide, prednisone, prednisolone, or methylprednisolone
  • Known renal or hepatic dysfunction
  • Impending respiratory failure requiring positive pressure ventilation
  • Immune deficiency
  • Gastroesophageal reflux disease
  • Suspected foreign body aspiration or croup
  • Anatomic abnormalities of the respiratory tract

Treatment and study plan

Budesonide 0.5 mg/ml nebules

Drug

Children will receive 1 mg nebulized budesonide 2 times a day up to 5 days

Other names: Pulmicort 0.5 mg/ml nebules

% 0.9 Saline solution

Drug

Children will receive 2 ml of nebulized saline 2 times a day up to 5 days

Primary outcomes

  1. Time to discharge from the hospital to home

    Time frame: 1-5 days

Secondary outcomes

  1. Pulmonary index score

    Time frame: 1 to 5 days

  2. Respiratory rate

    Time frame: 1 to 5 days

  3. Oxygen saturation

    Time frame: 1 to 5 days

  4. Adverse reactions.

    Time frame: 1 to 5 days

Sponsors and collaborators

Lead sponsor

Kecioren Education and Training Hospital

Other

Registry information

Official study title

Phase 4 Study of Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing

Important dates

Study start
2007
Primary completion
2009
Study completion
2010
First posted
Aug 13, 2008
Registry last updated
Dec 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.